Barbara Clendenen is the Chief Business Development Officer at ELIQUENT Life Sciences. Prior to this, Barbara held various business development roles at companies such as NDA Group AB, Synowledge LLC, Meeting Protocol Worldwide, Quorum Review IRB, Bio-Rad Laboratories, Humana, and Thermo Fisher Scientific. Barbara holds a Master's in Business Administration from Seattle University and a Bachelor's in Microbiology from the University of Washington.
Sign up to view 2 direct reports
Get started